Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: A pilot study

Journal of Veterinary Emergency and Critical Care

Volumn 22, Issue 1, 2012, Pages 126-130

  O'Marra, Shana K ^a,b   Shaw, Scott P ^a   DeLaforcade, Armelle M ^a  

^a TUFTS UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Coagulation; Hemostasis; Platelet function

Indexed keywords

CANIS FAMILIARIS;

IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; ERYTHROCYTE TRANSFUSION; FEMALE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; THROMBOELASTOGRAPHY; THROMBOPHILIA;

ANIMALS; DOG DISEASES; DOGS; ERYTHROCYTE TRANSFUSION; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBELASTOGRAPHY; THROMBOPHILIA;

EID: 84864300655     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2011.00658.x     Document Type: Article

References (12)

1. Abrams-Ogg AC. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats. Vet Clin North Am Small Anim 2003; 33:1401-1418.
2. O'Marra SK, Delaforcade AM, Shaw SP. Immune-mediated thrombocytopenia in the dog: 73 cases (2002-2008). J Am Vet Med Assoc 2011; 238(3):346-352
3. Putsche JC, Kohn B. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003). J Am Anim Hosp Assoc 2008; 44:250-257.
4. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 2005; 15:9-16.
5. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100(6):1576-1584.
6. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood 1984; 63(6):1372-1375.
7. Kravitz MS, Shoenfeld Y. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005; 80(3):232-242.
8. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenia purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
9. Lewis DC, Meyers KM. Canine idiopathic thrombocytopenic purpura. J Vet Intern Med 1996; 10(4):207-218.
10. Mohamed SY, Abdel-Nabi I, Inam A, Bakr M, Tayeb KE, Saleh AM, Alzahrani H, Abdu SH. Systemic thromboembolic complications after laparoscopic splenectomy for idiopathic thrombocytopenic purpura in comparison to open surgery in the absence of anticoagulant prophylaxis. Hematol Oncol Stem Cell Ther 2010; 3(2):71-77.
11. Wasowicz M, Srinivas C, Meineri M, Banks B, McCluskey SA, Karkouti K. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Can J Anaesth 2008; 55(5):284-289.
12. Johansson PI, Bochsen, L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot forming variables, as evaluated by thromboelastography. Transfusion 2008; 48:2377-2383.